Citations 3
An Open-label Study Evaluating the Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of Tanruprubart Single Dose in Participants From North America and Europe With Guillain-Barré Syndrome (P3-19.004)
Ladha, Shafeeq, Grover, Kavita, Morrison, Glenn, Lin, Ping, Kroon, Henk‐André, Allen, Jeffrey, Ladha, Shafeeq , Mustafa, Rafid , Grover, Kavita Mohindra , Lin, Ping , Allen, Jeffrey
Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available
Long-Term (2-Year) Safety and Efficacy of Adjunctive ZX008 (Fenfluramine Hydrochloride Oral Solution) for Dravet Syndrome: Interim Results of an Ongoing Open-Label Extension Study (4684)
Sullivan, Joseph , Pringsheim, Milka, Farfel, Gail, Galer, Bradley S. , Morrison, Glenn, Lock, Michael , Gammaitoni, Arnold R. , Thiele, Elizabeth A. , Auvin, Stéphane , Knupp, Kelly G. , Wirrell, Elaine
Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available
Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens
Nabbout, Rima , Mistry, Arun, Zuberi, Sameer M. , Villeneuve, Nathalie , Gil‐Nagel, António , Sánchez-Carpintero, Rocı́o , Stephani, Ulrich , Laux, Linda , Chiron, Catherine, Farfel, Gail, Galer, Bradley S. , Morrison, Glenn, Lock, Michael , Group, for the FAiRE, DS Study, Riney, Kate , Zuberi, Sameer M , Sánchez-Carpintero, Rocío , Wirrell, Elaine , Knupp, Kelly G. , Agarwal, Anupam , Auvin, Stéphane , Group, for the FAiRE, DS Study, Gil-Nagel, Antonio
JAMA Neurology | December 2, 2019 | Volume: 77 | Issue: 3 | Pages: 300